SOURCE: sound-eklin

sound-eklin

November 16, 2009 09:00 ET

sound-eklin Announces Exclusive Partnership With GE Healthcare to Meet Veterinary Ultrasound Needs

CARLSBAD, CA--(Marketwire - November 16, 2009) - sound-eklin, the leading provider of digital radiography, PACS (Picture Archiving and Communications Systems) and diagnostic ultrasound solutions for veterinary care, announced today that it is the exclusive provider of GE Healthcare ultrasound systems for the veterinary marketplace. GE Healthcare is the worldwide leader in ultrasound system sales according to the Klein Biomedical 2008 Ultrasound Industry Report.

"The portable LOGIQ e system with its great image quality and ease-of-use allows our staff to quickly and confidently recognize pathology," said Chris Franklin, DVM of Montrose, Colorado, who recently added a LOGIQ e, compact ultrasound system to his busy mixed animal practice. "The customized presets make it easier to obtain a high quality image on any patient size. As a result, we have an increased level of diagnostic confidence, which has grown our billable ultrasound caseload by 40 percent in the last six months."

sound-eklin is focused on helping veterinarians improve their diagnostic abilities by providing effective imaging technologies. Recent advancements by GE in image quality, ease-of-use and portability have increased the effectiveness of ultrasound in equine, small animal and exotics applications.

GE has successfully migrated beneficial technologies such as Spectral Reduction Imaging (SRI) and Crossbeam imaging through their family of products, including the company's compact ultrasound consoles. Both SRI and Crossbeam allow the veterinary sonographer to more confidently identify subtle lesions in veterinary patients.

Fusion Imaging, GE's latest premium ultrasound system capability, allows the sonographer to link imported MRI and CT studies to a real time ultrasound exam on the same patient. These linked exams allow the user to accurately correlate lesions visible on the CT or MRI study with ultrasound in real time. This correlated lesion technology allows more accurate lesion identification in multiple planes as well as improved overall biopsy sample accuracy.

"sound-eklin is pleased to provide veterinarians total access to GE's diagnostic ultrasound product line offering complete solutions from general practice settings to university level applications. As a result, veterinarians now have access to the most comprehensive ultrasound imaging with excellent ease-of-use, portability and new levels of image quality that result in a more confident diagnosis for veterinarians, and better care for their patients," commented Tom Jacobi, vice president sales for sound-eklin.

About sound-eklin

Based in Carlsbad, Calif., sound-eklin produces the most widely accepted and used digital radiography and PACS systems in the veterinary industry. sound-eklin holds leadership positions in ultrasound, digital radiography and education, and its mission is to simplify and advance veterinary medicine through diagnostic imaging. sound-eklin is a division of VCA ANTECH, INC. (NASDAQ: WOOF), and is dedicated to the field of veterinary imaging and education. VCA ANTECH also owns, operates and manages the largest network of freestanding veterinary hospitals and veterinary-exclusive clinical laboratories in the U.S. and employs approximately 12,000 professionals throughout North America. To contact sound-eklin, call 1-800-268-5354 or visit www.soundeklin.com.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company. Worldwide, GE Healthcare employs more than 46,000 people committed to serving professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com

Statements in this release that are not historical are forward-looking statements. These statements are based on management's current beliefs and expectations, including the statements as to the expected growth, innovation and other benefits of the combination of the two companies. Actual results may vary substantially as a result of a variety of factors. Among the important factors that could cause actual results to differ are: the ability to successfully integrate the two companies and achieve expected operating synergies following the merger; the rate of the Company's laboratory internal revenue growth and animal hospital same-store revenue growth; the level of direct costs and the ability of the Company to maintain revenue at a level necessary to maintain expected operating margins; the level of selling, general and administrative costs; the effects of the Company's recent acquisitions and its ability to effectively manage its growth and achieve operating synergies; a continued decline in demand for some of the Company's products and services; any disruption in the Company's information technology systems or transportation networks; the effects of competition; any impairment in the carrying value of the Company's goodwill; changes in prevailing interest rates; the Company's ability to service its debt; and general economic conditions. These and other risk factors are discussed in the Company's periodic reports filed with the Securities and Exchange Commission, including the Company's Report on Form 10-K for the year ended December 31, 2008, and the reader is directed to these statements for a further discussion of important factors that could cause actual results to differ materially from those in the forward-looking statements.

Contact Information